IndraLab

Statements


| 2

reach
"Both VA and cetirizine significantly reduced type I hypersensitivity itch in patients with AD, compared with both placebo and NI."

reach
"Both VA and cetirizine significantly reduced type-I-hypersensitivity itch in AD patients, compared to both placebo and NI."